Results 131 to 140 of about 12,551 (184)

Protective effect of long-chain polyunsaturated fatty acids on hepatorenal syndrome in rats. [PDF]

open access: yesWorld J Nephrol
Duailibe JBB   +4 more
europepmc   +1 more source

Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome. [PDF]

open access: yesCochrane Database Syst Rev
Gonzalez-Garay AG   +4 more
europepmc   +1 more source

Hepatorenal syndrome

Nature Reviews Disease Primers, 2018
Hepatorenal syndrome (HRS) is a form of kidney function impairment that characteristically occurs in cirrhosis. Recent changes in terminology have led to acute HRS being referred to as acute kidney injury (AKI)-HRS and chronic HRS as chronic kidney disease (CKD)-HRS.
Elsa Sola   +2 more
exaly   +7 more sources

Hepatorenal Syndrome

Critical Care Clinics, 2021
Development of acute kidney injury in patients with chronic liver disease is common and portends a poor prognosis. Diagnosis remains challenging, as traditional markers, such as serum creatinine, are not reliable. Recent development of novel biomarkers may assist with this.
Saro, Khemichian   +4 more
openaire   +2 more sources

Hepatorenal Syndrome

Expert Opinion on Pharmacotherapy, 2011
Hepatorenal syndrome (HRS) is a functional renal failure that often occurs in patients with cirrhosis and ascites. Two different types of HRS have been described. Type 1 HRS develops as a consequence of a severe reduction of effective circulating volume due to both an extreme splanchnic arterial vasodilatation and a reduction of cardiac output.
ANGELI, PAOLO   +3 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy